Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment

Guoyao Peng,* Yun Zhang,* Shuang Zhang,* You Li, Liping Luo, Jiaxin Luo, Xinyi Nie, Hongwei Zhang, Chengcheng Liao Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan Province, People’s Republic of China*These authors contributed equally...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng G, Zhang Y, Zhang S, Li Y, Luo L, Luo J, Nie X, Zhang H, Liao C
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Biologics: Targets & Therapy
Subjects:
Online Access:https://www.dovepress.com/generalized-pustular-psoriasis-with-cushings-syndrome-a-case-of-effect-peer-reviewed-fulltext-article-BTT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849312213204992000
author Peng G
Zhang Y
Zhang S
Li Y
Luo L
Luo J
Nie X
Zhang H
Liao C
author_facet Peng G
Zhang Y
Zhang S
Li Y
Luo L
Luo J
Nie X
Zhang H
Liao C
author_sort Peng G
collection DOAJ
description Guoyao Peng,* Yun Zhang,* Shuang Zhang,* You Li, Liping Luo, Jiaxin Luo, Xinyi Nie, Hongwei Zhang, Chengcheng Liao Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chengcheng Liao, Yunnan University of Traditional Chinese Medicine, No. 1076, Yuhua Road, Chenggong District, Kunming, Yunnan Province, People’s Republic of China, Email liaochengcheng2024@163.comAbstract: Generalized pustular psoriasis (GPP) is a rare neutrophilic skin disease characterized by persistent symptoms and sudden onset of painful, sterile pustules. These pustules may be accompanied by systemic inflammation and can be life-threatening in severe cases. Presently, there is an absence of standardized guidelines for treatment, and the majority of conventional treatments employed by clinicians are predicated on the utilization of glucocorticosteroids, immunosuppressants, and retinoids to attain anti-inflammatory and immune-suppressing effects. However, the therapeutic effect is often unsatisfactory and patients are prone to side effects. The IL-36 receptor monoclonal antibody, Spesolimab, signifies a novel therapeutic modality that has received approval from both the National Drug Administration (NMPA) of China and the US Food and Drug Administration (FDA) for the management of acute exacerbations of GPP. We report a case of a 40-year-old male patient diagnosed with GPP who had no significant improvement in symptoms and development of Cushing’s syndrome after up to six months of treatment with glucocorticoids, immunosuppressants, and retinoids. The patient was treated with Spesolimab, a monoclonal antibody, resulting in a substantial improvement in symptoms. This development offers novel treatment options and provides a reference for clinical medication for patients with this particular type of GPP.Keywords: generalized pustular psoriasis, spesolimab, biologic agents, case report
format Article
id doaj-art-e0b2d6f8f8294c0eaaac25fe31ae3e18
institution Kabale University
issn 1177-5491
language English
publishDate 2025-05-01
publisher Dove Medical Press
record_format Article
series Biologics: Targets & Therapy
spelling doaj-art-e0b2d6f8f8294c0eaaac25fe31ae3e182025-08-20T03:53:11ZengDove Medical PressBiologics: Targets & Therapy1177-54912025-05-01Volume 19Issue 1321329102856Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab TreatmentPeng G0Zhang YZhang S1Li Y2Luo LLuo JNie XZhang HLiao C3First Affiliated HospitalFirst Clinical Medical Collegefirst school of clinical medicineFirst Affiliated HospitalGuoyao Peng,* Yun Zhang,* Shuang Zhang,* You Li, Liping Luo, Jiaxin Luo, Xinyi Nie, Hongwei Zhang, Chengcheng Liao Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chengcheng Liao, Yunnan University of Traditional Chinese Medicine, No. 1076, Yuhua Road, Chenggong District, Kunming, Yunnan Province, People’s Republic of China, Email liaochengcheng2024@163.comAbstract: Generalized pustular psoriasis (GPP) is a rare neutrophilic skin disease characterized by persistent symptoms and sudden onset of painful, sterile pustules. These pustules may be accompanied by systemic inflammation and can be life-threatening in severe cases. Presently, there is an absence of standardized guidelines for treatment, and the majority of conventional treatments employed by clinicians are predicated on the utilization of glucocorticosteroids, immunosuppressants, and retinoids to attain anti-inflammatory and immune-suppressing effects. However, the therapeutic effect is often unsatisfactory and patients are prone to side effects. The IL-36 receptor monoclonal antibody, Spesolimab, signifies a novel therapeutic modality that has received approval from both the National Drug Administration (NMPA) of China and the US Food and Drug Administration (FDA) for the management of acute exacerbations of GPP. We report a case of a 40-year-old male patient diagnosed with GPP who had no significant improvement in symptoms and development of Cushing’s syndrome after up to six months of treatment with glucocorticoids, immunosuppressants, and retinoids. The patient was treated with Spesolimab, a monoclonal antibody, resulting in a substantial improvement in symptoms. This development offers novel treatment options and provides a reference for clinical medication for patients with this particular type of GPP.Keywords: generalized pustular psoriasis, spesolimab, biologic agents, case reporthttps://www.dovepress.com/generalized-pustular-psoriasis-with-cushings-syndrome-a-case-of-effect-peer-reviewed-fulltext-article-BTTGeneralized Pustular PsoriasisSpesolimabBiologic AgentsCase Report
spellingShingle Peng G
Zhang Y
Zhang S
Li Y
Luo L
Luo J
Nie X
Zhang H
Liao C
Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
Biologics: Targets & Therapy
Generalized Pustular Psoriasis
Spesolimab
Biologic Agents
Case Report
title Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
title_full Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
title_fullStr Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
title_full_unstemmed Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
title_short Generalized Pustular Psoriasis with Cushing’s Syndrome: A Case of Effective Spesolimab Treatment
title_sort generalized pustular psoriasis with cushing amp rsquo s syndrome a case of effective spesolimab treatment
topic Generalized Pustular Psoriasis
Spesolimab
Biologic Agents
Case Report
url https://www.dovepress.com/generalized-pustular-psoriasis-with-cushings-syndrome-a-case-of-effect-peer-reviewed-fulltext-article-BTT
work_keys_str_mv AT pengg generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment
AT zhangy generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment
AT zhangs generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment
AT liy generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment
AT luol generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment
AT luoj generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment
AT niex generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment
AT zhangh generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment
AT liaoc generalizedpustularpsoriasiswithcushingamprsquossyndromeacaseofeffectivespesolimabtreatment